Tag: COVID-19
Zydus receives approval for Phase III clinical trials with Pegylated Interferon...
Zydus Cadila recently announced that it had received approval from the Drugs Controller General of India (DCGI) to start the Phase 3 clinical trial...
Pfizer & Biontech achieve first authorization in the world for a...
Pfizer and BioNTech announced on 2 December 2020 that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the UK has granted a temporary...
Siemens offers a quantitative Covid-19 test to measure neutralizing antibodies
Siemens Healthineers announced that its SARS-CoV-2 IgG Antibody Test (sCOVG) has proven to measure neutralizing antibodies and has achieved CE Mark. The test is...
Philips Patient Management Solution keeps patients safe
Royal Philips, a global enterprise in health technology, recently announced it is working with leading medical centers to help respond to Covid-19 by increasing...
New Gea Pharma Separator line aseptic supports Sinovac
To be able to produce a vaccine against the corona virus Sars-CoV-2 in large quantities, quickly and safely, Gea is supplying further separator systems...
IIT Delhi’s Startup Nanosafe launches zero alcohol sanitizer
With the Covid-19 crisis still looming and the nation gradually shifting back to normal, there is a dire need for innovative solutions - now...
Gentili – the unilateral decision made by Interpack is unacceptable
After months of attempting to dialogue with the organizers of Interpack, up until now the world’s most important exhibition of packaging technologies, the Italian...
AISNMA assures India is ‘Atmanirbhar’ for syringes
In a letter addressed to India's prime minister and sent on 24 November 2020, the All India Syringe and Needle Manufacturers Association (AISNMA) has...
‘We are living in a phase of a silent war’, says...
Dr Harsh Vardhan, union minister for Health and Family Welfare, digitally addressed the Boston Center of Excellence for Health and Human Development through Video...
Indigenous solution to Covid-19 in progress
To fight the novel coronavirus SARS-COV-2, the virus behind the worldwide outbreak of Covid-19 disease, a Nagpur based Indian biotechnology company, GeNext Genomics (GNG),...